Jennifer Wu is currently an Assistant Professor (Associated Professor will be effective on July 01, 2011) at the University of Washington. Dr. Wu received her Ph.D. degree in fungal genetics from the University of British Columbia in 2000 and subsequently entered the tumor immunology training program at Fred Hutchinson Cancer Research Center. In 2003, she joined the faculty at the Department of Medicine at the University of Washington and established the research program of tumor immunology and tumor microenvironment program in prostate cancer. Dr. Wu is also a Consortium Member of the Fred Hutchinson Cancer Research Center. She has been a Member of the DOD-USARMC and NIH tumor immunology grant review committee and served as a reviewer for multiple journals. Her research is focused on two major areas of the prostate cancer. One is focused on prostate tumor immunity. Research in Dr. Wu’s laboratory has defined for the first time that prostate tumor progression is associated with prostate tumor immunoediting of the innate NK cell antitumor immunity and has established the very unique and first double-transgenic animals model to further define the impact of immunoediting in prostate tumor initiation and progression. The other area of her research is tissue microenvironment, namely, inflammation, in prostate tumor initiation and progression. Dr. Wu’s laboratory has shown for the first time that the multifunctional cytokine IL-6 can develop into prostate tumor and further progress to metastasis through the autocrine activation of type I insulin-like growth factor receptor (IGF-IR).
Biography Updated on 28 December 2010